Content area

Abstract

Overuse of antibiotics is one of the important factors that contribute to developing antimicrobial resistance. Many studies have been conducted to find out promising solutions to overcome the problems. Antimicrobial peptides (AMPs) are fundamental components of human innate immunity. They have an important role in the treatment of a wide range of diseases, including cancer, allergies, and also in warding off invading pathogens. In the case of infectious disease, the AMPs exhibit broad-spectrum activity against a wide range of pathogens including Gram-positive and -negative bacteria, yeasts, fungi, and enveloped viruses. These peptides have been isolated from various sources such as microorganisms, plants, invertebrates, and vertebrates. The peptides show distinct physicochemical and structural properties but most of them are small cationic peptides with amphipathic properties. In this review, an overview of the classification, antimicrobial activities, mode of action, and mechanism of resistance of human AMPs will be provided. These peptides are categorized into three main groups. The defensins are cationic peptides containing six cysteine residues with three intramolecular disulfide bridges. In humans, two classes of defensins could be found, α-defensins and β-defensins. The second group is cathelicidins that only one AMP, LL-37, has been found in humans. This peptide is derived from proteolytic digestion of the C-terminal of human CAP18 protein. The third group is the family of histatins that are small cationic histidine-rich peptides, and mainly present in human saliva. The last two groups have random coil conformation in hydrophilic environments and α-helices in a hydrophobic environment.

Details

Title
Human Antimicrobial Peptides: Spectrum, Mode of Action and Resistance Mechanisms
Author
Fazly Bazzaz Bibi Sedigheh 1 ; Seyedi Shabnam 2 ; Hoseini Goki Narjes 2 ; Khameneh Bahman 3   VIAFID ORCID Logo 

 Mashhad University of Medical Sciences, Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad, Iran (GRID:grid.411583.a) (ISNI:0000 0001 2198 6209); Mashhad University of Medical Sciences, Department of Pharmaceutical Control, School of Pharmacy, Mashhad, Iran (GRID:grid.411583.a) (ISNI:0000 0001 2198 6209) 
 Mashhad University of Medical Sciences, School of Pharmacy, Mashhad, Iran (GRID:grid.411583.a) (ISNI:0000 0001 2198 6209) 
 Mashhad University of Medical Sciences, Department of Pharmaceutical Control, School of Pharmacy, Mashhad, Iran (GRID:grid.411583.a) (ISNI:0000 0001 2198 6209) 
Pages
801-816
Publication year
2021
Publication date
Mar 2021
Publisher
Springer Nature B.V.
ISSN
15733149
e-ISSN
15733904
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2488778588
Copyright
© Springer Nature B.V. 2020.